Trial Profile
A phase I study evaluating the safety and pharmacokinetics of trabectedin in combination with docetaxel in patients with advanced malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Trabectedin (Primary)
- Indications Cancer
- Focus Adverse reactions
- 02 Sep 2015 New trial record